Fluoroestradiol (FES) Positron Emission Tomography (PET) Reveals Differences In Pharmacodynamics Of Aromatase Inhibitors, Tamoxifen, And Fulvestrant In Patients With Metastatic Breast Cancer

PURPOSE: To determine, by molecular imaging, how in vivo pharmacodynamics of estrogen-estrogen receptor (ER) binding differ between types of standard endocrine therapy. EXPERIMENTAL DESIGN: The estrogen receptor (ER) has been a highly successful target for breast cancer treatment. ER-directed treatm...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Linden, Hannah M., Kurland, Brenda F., Peterson, Lanell M., Schubert, Erin K., Gralow, Julie R., Specht, Jennifer M., Ellis, Georgiana K., Lawton, Thomas, Livingston, Robert B., Petra, Philip H., Link, Jeanne M., Krohn, Kenneth A., Mankoff, David A.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2011
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3139698/
https://ncbi.nlm.nih.gov/pubmed/21750198
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-3321
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge